Search results
Results from the WOW.Com Content Network
AmerisourceBergen's (ABC) fiscal third-quarter results are likely to reflect solid performance at Pharmaceutical Distribution and Other units.
Is AmerisourceBergen (ABC) a great pick from the value investor's perspective right now? Read on to know more.
AmerisourceBergen (ABC) possesses solid growth attributes, which could help it handily outperform the market. Is AmerisourceBergen (ABC) a Solid Growth Stock? 3 Reasons to Think "Yes" Skip to main ...
AmerisourceBergen (ABC) is well positioned to outperform the market, as it exhibits above-average growth in financials. AmerisourceBergen (ABC) is an Incredible Growth Stock: 3 Reasons Why Skip to ...
In March 2016 Walgreens Boots Alliance Inc. announced it would exercise an option to purchase 22.7 million shares of AmerisourceBergen stock and thereby control 15% of the company. In 2012, the firm was the largest by revenue based in Pennsylvania. The company has announced its intention to change its name to Cencora, effective in mid-2023.
AmerisourceBergen's (ABC) fiscal first-quarter results are likely to reflect solid performance at the U.S. Healthcare Solutions segment.
AmerisourceBergen (ABC) registers strong growth in the Pharmaceutical Distribution segment and the World Courier business in Q4. AmerisourceBergen (ABC) Beats on Q4 Earnings, Issues '19 View Skip ...
AmerisourceBergen (ABC) delivered earnings and revenue surprises of 5.26% and 3.23%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?